Literature DB >> 3095210

Cytotoxic and DNA-inhibitory effects of iron chelators on human leukaemic cell lines.

G J Kontoghiorghes, A Piga, A V Hoffbrand.   

Abstract

Cytotoxic and DNA synthesis inhibitory effects of several iron chelators with different physicochemical properties have been tested in four myeloid leukaemic cell lines (U937, K562, ML2 and HL60). The small lipophilic chelators 8-hydroxyquinoline, tropolone and omadine at 2 X 10(-5) M, caused substantial inhibition of labelled leucine and thymidine uptake into cells and also cell death following 4-h incubation. These effects were approximately 10-fold increased when the drugs were pre-incubated with equimolar amounts of iron. Iron alone and hydrophilic chelators e.g. desferrioxamine had insignificant cytotoxic and DNA synthesis inhibitory effects under the same conditions.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3095210     DOI: 10.1002/hon.2900040303

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN: 0278-0232            Impact factor:   5.271


  15 in total

1.  Uptake and intracellular distribution of iron from transferrin and chelators in erythroid cells.

Authors:  G J Kontoghiorghes; A May
Journal:  Biol Met       Date:  1990

2.  Iron chelation-induced senescence-like growth arrest in hepatocyte cell lines: association of transforming growth factor beta1 (TGF-beta1)-mediated p27Kip1 expression.

Authors:  Gyesoon Yoon; Hyun-Jung Kim; Young-Sil Yoon; Hyeseong Cho; In K Lim; Jae-Ho Lee
Journal:  Biochem J       Date:  2002-09-01       Impact factor: 3.857

3.  Induction to erythroid differentiation of K562 cells by 1-beta-D-arabinofuranosylcytosine is inhibited by iron chelators: reversion by treatment with hemin.

Authors:  G Feriotto; C Nastruzzi; R Barbieri; R Gambari
Journal:  Blut       Date:  1988-07

Review 4.  Benefits and risks of deferiprone in iron overload in Thalassaemia and other conditions: comparison of epidemiological and therapeutic aspects with deferoxamine.

Authors:  George J Kontoghiorghes; Katia Neocleous; Annita Kolnagou
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

5.  Mimosine, a novel inhibitor of DNA replication, binds to a 50 kDa protein in Chinese hamster cells.

Authors:  P J Mosca; H B Lin; J L Hamlin
Journal:  Nucleic Acids Res       Date:  1995-01-25       Impact factor: 16.971

6.  Iron depletion results in Src kinase inhibition with associated cell cycle arrest in neuroblastoma cells.

Authors:  Gamini Siriwardana; Paul A Seligman
Journal:  Physiol Rep       Date:  2015-03

Review 7.  Targeting cancer by binding iron: Dissecting cellular signaling pathways.

Authors:  Goldie Y L Lui; Zaklina Kovacevic; Vera Richardson; Angelica M Merlot; Danuta S Kalinowski; Des R Richardson
Journal:  Oncotarget       Date:  2015-08-07

8.  Deferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro and in vivo.

Authors:  Hirofumi Harima; Seiji Kaino; Taro Takami; Shuhei Shinoda; Toshihiko Matsumoto; Koichi Fujisawa; Naoki Yamamoto; Takahiro Yamasaki; Isao Sakaida
Journal:  BMC Cancer       Date:  2016-08-31       Impact factor: 4.430

Review 9.  New Era in the Treatment of Iron Deficiency Anaemia Using Trimaltol Iron and Other Lipophilic Iron Chelator Complexes: Historical Perspectives of Discovery and Future Applications.

Authors:  George J Kontoghiorghes; Annita Kolnagou; Theodora Demetriou; Marina Neocleous; Christina N Kontoghiorghe
Journal:  Int J Mol Sci       Date:  2021-05-24       Impact factor: 5.923

10.  Two cell cycle blocks caused by iron chelation of neuroblastoma cells: separating cell cycle events associated with each block.

Authors:  Gamini Siriwardana; Paul A Seligman
Journal:  Physiol Rep       Date:  2013-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.